Literature DB >> 2265495

Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels.

O Pos1, M E van der Stelt, G J Wolbink, M W Nijsten, G L van der Tempel, W van Dijk.   

Abstract

The relation between interleukin-6 (IL-6) levels and changes in serum concentrations and glycosylation (concanavalin A affinity) of two human acute-phase glycoproteins, alpha 1-acid glycoprotein (AGP) and alpha 1-protease inhibitor (PI), was studied in sequential serum samples of burn patients. The level of IL-6 was already increased at the first day following injury, and after a dip at day 2 or 3 rapidly reached a second maximal value at day 4 or 5. The serum concentrations of AGP and PI reached their maximal values after day 5 and remained at a high level throughout the total period studied (7 weeks). The concanavalin A reactivities of both acute-phase glycoproteins were found to be elevated only during the first 2-2.5 weeks. Maximal values were observed on day 2 and from day 7 to 16, following closely the rise and fall of the IL-6 serum level. After day 16, the concanavalin A affinity rapidly declined long before a decrease was observed in the serum concentrations of AGP and PI. Our previous in vitro studies have indicated an involvement of IL-6 in the induction of both secretion and increased concanavalin A affinity. This study indicates that IL-6 could play a causal role in the induction of both phenomena in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265495      PMCID: PMC1535518          DOI: 10.1111/j.1365-2249.1990.tb05493.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

2.  Evidence for uniformity of the carbohydrate chains in individual glycoprotein molecular variants.

Authors:  B Bayard; J P Kerckaert
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

Review 3.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Effects of monocytic products, recombinant interleukin-1, and recombinant interleukin-6 on glycosylation of alpha 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats.

Authors:  O Pos; H J Moshage; S H Yap; J P Snieders; L A Aarden; J van Gool; W Boers; A M Brugman; W van Dijk
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

5.  alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms.

Authors:  L Vaughan; M A Lorier; R W Carrell
Journal:  Biochim Biophys Acta       Date:  1982-03-04

6.  Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease.

Authors:  J Raynes
Journal:  Biomed Pharmacother       Date:  1982-03       Impact factor: 6.529

7.  Evidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man.

Authors:  I Nicollet; J P Lebreton; M Fontaine; M Hiron
Journal:  Biochim Biophys Acta       Date:  1981-04-28

8.  Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse.

Authors:  H Baumann; G P Jahreis; D N Sauder; A Koj
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

9.  Glucocorticoids and catecholamines as mediators of acute-phase proteins, especially rat alpha-macrofoetoprotein.

Authors:  J van Gool; W Boers; M Sala; N C Ladiges
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

10.  Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

Authors:  G Ramadori; J D Sipe; C A Dinarello; S B Mizel; H R Colten
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  16 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

2.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

3.  Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes.

Authors:  Peter Gunnarsson; Louise Fornander; Peter Påhlsson; Magnus Grenegård
Journal:  Inflamm Res       Date:  2009-08-11       Impact factor: 4.575

Review 4.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

5.  Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Authors:  Kevin S Akers; Matthew P Rowan; Krista L Niece; Ian J Stewart; Katrin Mende; Jason M Cota; Clinton K Murray; Kevin K Chung
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

Review 6.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

7.  Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

8.  Abnormal glycosylation of alpha 2-macroglobulin, a non-acute-phase protein in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; A Guglielmotti; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Distinct glycoforms of human alpha1-acid glycoprotein have comparable synthesis rates: a [13C]valine-labelling study in healthy humans.

Authors:  Dennis C W Poland; Willem Kulik; Willem van Dijk; Marcella M Hallemeesch; Cornelis Jakobs; Kees de Meer
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver.

Authors:  E C Havenaar; R C Hoff; D H van den Eijnden; W van Dijk
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.